Today: 16 May 2026
CBA share price: two dates that could move Commonwealth Bank stock next
1 February 2026
1 min read

CBA share price: two dates that could move Commonwealth Bank stock next

Sydney, Feb 1, 2026, 16:54 AEDT — Market closed

The Commonwealth Bank of Australia share price (CBA.AX) closed Friday 0.47% higher at A$149.36. It fluctuated between A$148.33 and A$150.10 during the session, with roughly 2.32 million shares traded.

Australia’s S&P/ASX 200 dropped 0.7% on Friday, closing at 8,869.10 as miners and gold stocks pulled back amid profit-taking. Still, the index notched a 1.8% gain for January—the biggest monthly jump since August. Financials edged up 0.5%, with the big four banks rising between 0.5% and 0.8%. “Earnings season will be key to judging whether these recent gains hold at the stock level,” said Marc Jocum, senior product and investment strategist at Global X ETFs. Meanwhile, money markets are pricing in over a 75% chance of a 25 basis point hike at the Reserve Bank of Australia’s Tuesday meeting. Indo Premier

The RBA’s cash rate target remains at 3.60%. The central bank will release its policy decision statement at 2:30 pm AEDT on Feb. 3, wrapping up a two-day meeting. A media conference follows an hour later, at 3:30 pm.

Bank stocks react to rates in two key ways: they influence earnings on new loans and alter how investors value steady dividends compared to bond yields. When expectations shift abruptly, the sector can move fast—often ahead of earnings reports.

Commonwealth Bank is set to unveil its half-year results for the period ending Dec. 31, 2025, on Feb. 11, per its investor calendar. Market watchers will focus on updates around mortgage growth, deposit competition, and cost pressures.

CBA’s shares often set the tone for the sector, so even minor tweaks in margin guidance tend to ripple through the market. Investors will also be watching closely to see how CBA compares with rivals Westpac, National Australia Bank, and ANZ as earnings season progresses.

That said, the situation isn’t one-sided. Should the RBA tighten and hint at further hikes, investors might shift focus to rising funding costs and the threat of weaker credit demand instead of near-term earnings boosts. Conversely, a surprise pause could unsettle markets if they’re heavily tilted in the opposite direction.

Monday’s trading will reveal if Friday’s shift into financials holds up after global markets recalibrated. The real focus, however, is the RBA statement—especially its take on inflation and employment.

Stock Market Today

  • PVH Shares Drop 3% as April Inflation Surges to 3.8% Annual Rate
    May 15, 2026, 8:16 PM EDT. PVH shares fell 3% following the latest Consumer Price Index report showing inflation at a 3.8% annual rate in April, the fastest since 2023. Energy costs, notably a 5.4% rise in gasoline prices linked to the Iran conflict, sharply increased. Higher prices for essentials like food and shelter raised concerns over reduced consumer spending on discretionary items, impacting retail and consumer goods sectors. PVH's stock, volatile with 14 moves over 5% in the past year, reacted moderately compared to a recent 7.7% drop amid crude oil price surges and weak consumer sentiment. Goldman Sachs lowered its 2026 discretionary cash flow forecast from 5.1% to 3.7%, citing squeezed consumer budgets. PVH trades 18% below its 52-week high, with long-term investors facing a decline in value.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings
Previous Story

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings

Saks Off 5th liquidation sales begin as Saks Global moves to close 57 stores
Next Story

Saks Off 5th liquidation sales begin as Saks Global moves to close 57 stores

Go toTop